In a significant development for the Indian pharmaceutical industry, Kuala Lumpur-based private equity firm Creador has acquired a 7% stake in Ahmedabad-headquartered La Renon Healthcare for ₹800 crore. This investment values La Renon at nearly ₹11,000 crore, marking a major milestone in the company’s rapid growth journey and reflecting robust investor confidence in India’s pharmaceutical sector.
Background of the Deal
The new transaction builds on La Renon’s earlier funding successes and sharp valuation rise. Post-deal, the promoter family led by Pankaj Singh retains a controlling 66% stake, while private equity investors including ChrysCapital, Peak XV Partners, A91 Partners, and Avendus collectively hold 34%. Specifically, the promoter family is selling about 5% of equity, with Peak XV offloading around 2% to accommodate the new investment.
Free Membership Required
You must be a Free member to access this content.
